Duopharma Biotech Berhad (KLSE:DPHARMA)

Malaysia flag Malaysia · Delayed Price · Currency is MYR
1.500
+0.020 (1.35%)
At close: Mar 6, 2026
23.97%
Market Cap 1.34B
Revenue (ttm) 931.69M
Net Income (ttm) 87.46M
Shares Out 961.94M
EPS (ttm) 0.09
PE Ratio 15.29
Forward PE 13.24
Dividend 0.05 (3.03%)
Ex-Dividend Date Mar 12, 2026
Volume 1,545,200
Average Volume 1,483,280
Open 1.470
Previous Close 1.480
Day's Range 1.450 - 1.520
52-Week Range 1.070 - 1.570
Beta 0.38
RSI 44.76
Earnings Date Feb 19, 2026

About Duopharma Biotech Berhad

Duopharma Biotech Berhad, an investment holding company, researches, develops, manufactures, distributes, and imports pharmaceutical products and medicines in Malaysia and internationally. The company offers consumer healthcare products, such as vitamins, minerals, and supplements, analgesics, eyecare, antacids, and skin care products; and generic drugs for various therapeutic classes, such as cardiovascular, dermatology, hormones, respiratory, sensory and nervous system, musculo-skeletal system, anti-infectives, and others. It also provides sp... [Read more]

Industry Pharmaceutical Preparations
Founded 1978
Employees 1,957
Stock Exchange Bursa Malaysia
Ticker Symbol DPHARMA
Full Company Profile

Financial Performance

In 2025, Duopharma Biotech Berhad's revenue was 931.69 million, an increase of 14.50% compared to the previous year's 813.70 million. Earnings were 87.46 million, an increase of 39.62%.

Financial Statements

News

There is no news available yet.